Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

March 24, 2023 13:44 ET | Source: Robbins LLP

Invivyd, Inc. (IVVD) Investor Alert: Robbins LLP Reminds Investors of Pending Lead Plaintiff Deadline in Invivyd, Inc. Class Action

SAN DIEGO, March 24, 2023 (GLOBE NEWSWIRE) -- The Class: Robbins LLP reminds investors that a shareholder filed a class action on behalf of all purchasers of Invivyd, Inc. (NASDAQ: IVVD) f/k/a...
February 22, 2023 17:24 ET | Source: Robbins LLP

Invivyd, Inc. (IVVD) Class Action Notice: Contact Robbins LLP for Information About Filing a Lead Plaintiff Motion in Class Action Against Invivyd, Inc.

SAN DIEGO, Feb. 22, 2023 (GLOBE NEWSWIRE) -- The Class: Robbins LLP reminds investors that a shareholder filed a class action on behalf of all purchasers of Invivyd, Inc. (NASDAQ: IVVD) f/k/a...
February 16, 2023 15:03 ET | Source: Robbins LLP

Invivyd, Inc. (IVVD) Class Action Alert: Robbins LLP Urges Shareholders to Contact the Firm Regarding Representation in the Class Action Against Invivyd, Inc.

SAN DIEGO, Feb. 16, 2023 (GLOBE NEWSWIRE) -- The Class: Robbins LLP reminds investors that a shareholder filed a class action on behalf of all purchasers of Invivyd, Inc. (NASDAQ: IVVD) f/k/a...
February 07, 2023 13:05 ET | Source: Robbins LLP

Invivyd, Inc. (IVVD) f/k/a Adagio Therapeutics, Inc. Shareholder Notice: Robbins LLP Informs Investors of Class Action Against Invivyd, Inc. f/k/a Adagio Therapeutics, Inc.

SAN DIEGO, Feb. 07, 2023 (GLOBE NEWSWIRE) -- The Class: Robbins LLP reminds investors that a shareholder filed a class action on behalf of all purchasers of Invivyd, Inc. (NASDAQ: IVVD) f/k/a...